Adagio Medical Holdings, Inc.
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
ADGM$1.92Day change unavailableStored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | |
|---|---|---|
| | ADAGIO MEDICAL HOLDINGS, INC. | |
| | | |
| Date: March 27, 2025 | | /s/ Todd Usen |
| | Name: | Todd Usen |
| | Title: | Director and Chief Executive Officer |
| | | |
| Date: March 27, 2025 | | /s/ John Dahldorf |
| | Name: | John Dahldorf |
| | Title: | Chief Financial Officer |
| | | |
| Date: March 27, 2025 | | /s/ James L. Cox |
| | Name: | James L. Cox |
| | Title: | Director |
| | | |
| Date: March 27, 2025 | | /s/ Orly Mishan |
| | Name: | Orly Mishan |
| | Title: | Director |
| | | |
| Date: March 27, 2025 | | /s/ Keyvan Mirsaeedi-Farahani |
| | Name: | Keyvan Mirsaeedi-Farahani |
| | Title: | Director |
| | | |
| Date: March 27, 2025 | | /s/ Timothy Moran |
| | Name: | Timothy Moran |
| | Title: | Director |
| | | |
| Date: March 27, 2025 | | /s/ Sandra Gardiner |
| | Name: | Sandra Gardiner |
| | Title: | Director |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.